US Congress House Bill 2038 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on April 2 2019 - 25% progression, died in committee
Action: 2019-05-15 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Pending: House Subcommittee on Antitrust, Commercial, and Administrative Law Committee
Text: Latest bill text (Introduced) [PDF]

Authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

Rep. Mark Meadows [R-NC]

Sen. Ted Budd [R-NC]

Rep. Debbie Lesko [R-AZ]

Date	Chamber	Action
2019-05-15	House	Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
2019-04-02	House	Referred to the House Committee on the Judiciary.
2019-04-02	House	Introduced in House

SB4796 (Related) 2020-10-05 - Read twice and referred to the Committee on Finance.
HB8527 (Related) 2020-10-02 - Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, the Judiciary, Oversight and Reform, House Administration, Rules, the Budget, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/2038/all-info
Text	https://www.congress.gov/116/bills/hr2038/BILLS-116hr2038ih.pdf